Loading…

Findings on 3D speckle tracking echocardiography in asymptomatic methamphetamine abusers

To detect potential cardiac abnormalities in asymptomatic methamphetamine abusers using three-dimensional speckle tracking echocardiography (3D STE). Fifty-three male methamphetamine abusers, free of cardiac symptoms/signs, were enrolled in this study. A control group of 53 age-matched male normal s...

Full description

Saved in:
Bibliographic Details
Published in:The International Journal of Cardiovascular Imaging 2018-10, Vol.34 (10), p.1589-1593
Main Authors: Zhang, Li-Juan, Chen, Ke-Qi, Shi, Yun-Yan, Qiao, Xiao-Ling, Wang, Lian-You, Zheng, Xiao-Zhi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c372t-f0f0bc1239e4307c62857f22064eb493aa1d1e09e01f994fadf8abb918afae8c3
cites cdi_FETCH-LOGICAL-c372t-f0f0bc1239e4307c62857f22064eb493aa1d1e09e01f994fadf8abb918afae8c3
container_end_page 1593
container_issue 10
container_start_page 1589
container_title The International Journal of Cardiovascular Imaging
container_volume 34
creator Zhang, Li-Juan
Chen, Ke-Qi
Shi, Yun-Yan
Qiao, Xiao-Ling
Wang, Lian-You
Zheng, Xiao-Zhi
description To detect potential cardiac abnormalities in asymptomatic methamphetamine abusers using three-dimensional speckle tracking echocardiography (3D STE). Fifty-three male methamphetamine abusers, free of cardiac symptoms/signs, were enrolled in this study. A control group of 53 age-matched male normal subjects was studied for comparison. Standard 3D, flow and tissue Doppler echo with measurements of left ventricular end-diastolic volume (LVEDV), end-systolic volume (LVESV), ejection fraction (LVEF), the ratio of the early to late diastolic transmitral filling velocity (E/A), the ratio of the early diastolic transmitral filling velocity to the early diastolic septal tissue velocity (E/E′) and 3D STE with measurements of global area strain (GAS), global longitudinal strain (GLS), global circumferential strain (GCS) and global radial strain (GRS) were performed, respectively. These echocardiographic parameters were compared between methamphetamine abusers and normal subjects, and receiver operating characteristic curve (ROC) analysis was done to differentiating methamphetamine abusers from normal subjects. LVESV, LVEDV, LVEF, E/A, E/E′ ratios and GRS were not significantly different between methamphetamine abusers and normal subjects ( p  > 0.05). However, GAS, GLS and GCS were significantly less in methamphetamine abusers than in normal subjects ( p  
doi_str_mv 10.1007/s10554-018-1381-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2045809897</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2045809897</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-f0f0bc1239e4307c62857f22064eb493aa1d1e09e01f994fadf8abb918afae8c3</originalsourceid><addsrcrecordid>eNp1kD1PwzAQhi0EoqXwA1iQJebA2U5ie0SFAlIlFpDYLMc5t2mbD-x06L8nVQtMTHe6ez-kh5BrBncMQN5HBlmWJsBUwoRiSX5CxiyTIgGZitP9nuskkzodkYsYVwDAgYtzMuJagRJKjsnnrGrKqllE2jZUPNLYoVtvkPbBuvVwp-iWrbOhrNpFsN1yR6uG2riru76tbV85WmO_tHW3xN7WVYPUFtuIIV6SM283Ea-Oc0I-Zk_v05dk_vb8On2YJ05I3icePBSOcaExFSBdzlUmPeeQp1ikWljLSoagEZjXOvW29MoWhWbKeovKiQm5PeR2of3aYuzNqt2GZqg0HNJMgVZaDip2ULnQxhjQmy5UtQ07w8DsWZoDSzOwNHuWJh88N8fkbVFj-ev4gTcI-EEQh1ezwPBX_X_qN8XygCU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2045809897</pqid></control><display><type>article</type><title>Findings on 3D speckle tracking echocardiography in asymptomatic methamphetamine abusers</title><source>Springer Nature</source><creator>Zhang, Li-Juan ; Chen, Ke-Qi ; Shi, Yun-Yan ; Qiao, Xiao-Ling ; Wang, Lian-You ; Zheng, Xiao-Zhi</creator><creatorcontrib>Zhang, Li-Juan ; Chen, Ke-Qi ; Shi, Yun-Yan ; Qiao, Xiao-Ling ; Wang, Lian-You ; Zheng, Xiao-Zhi</creatorcontrib><description>To detect potential cardiac abnormalities in asymptomatic methamphetamine abusers using three-dimensional speckle tracking echocardiography (3D STE). Fifty-three male methamphetamine abusers, free of cardiac symptoms/signs, were enrolled in this study. A control group of 53 age-matched male normal subjects was studied for comparison. Standard 3D, flow and tissue Doppler echo with measurements of left ventricular end-diastolic volume (LVEDV), end-systolic volume (LVESV), ejection fraction (LVEF), the ratio of the early to late diastolic transmitral filling velocity (E/A), the ratio of the early diastolic transmitral filling velocity to the early diastolic septal tissue velocity (E/E′) and 3D STE with measurements of global area strain (GAS), global longitudinal strain (GLS), global circumferential strain (GCS) and global radial strain (GRS) were performed, respectively. These echocardiographic parameters were compared between methamphetamine abusers and normal subjects, and receiver operating characteristic curve (ROC) analysis was done to differentiating methamphetamine abusers from normal subjects. LVESV, LVEDV, LVEF, E/A, E/E′ ratios and GRS were not significantly different between methamphetamine abusers and normal subjects ( p  &gt; 0.05). However, GAS, GLS and GCS were significantly less in methamphetamine abusers than in normal subjects ( p  &lt; 0.05). The areas under ROC (AUC) for GAS were greatest among all the 3D STE derived LV global strains (GAS vs. GLS, GCS and GRS, 0.95 vs. 0.76, 0.69 and 0.61, respectively). The cutoff value with − 30.3% of GAS had sensitivity of 91.8%, specificity of 91.6% and accuracy of 91.3% for differentiating methamphetamine abusers from normal subjects. The potential myocardial function abnormalities can be detected by 3D STE in asymptomatic methamphetamine abusers, and GAS is a good indicator for indentifying methamphetamine abusers from normal population, which can be used to screening and monitor methamphetamine abuse, detect subclinical LV dysfunction, predict potential methamphetamine-related cardiotoxicity, and to initiate early cardioprotective therapy before the onset of overt heart failure in time.</description><identifier>ISSN: 1569-5794</identifier><identifier>EISSN: 1573-0743</identifier><identifier>EISSN: 1875-8312</identifier><identifier>DOI: 10.1007/s10554-018-1381-6</identifier><identifier>PMID: 29808387</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Abnormalities ; Adolescent ; Adult ; Amphetamine-Related Disorders - complications ; Cardiac Imaging ; Cardiology ; Cardiotoxicity ; Central Nervous System Stimulants - adverse effects ; Drug abuse ; Echocardiography ; Echocardiography, Three-Dimensional ; Heart ; Heart diseases ; Humans ; Imaging ; Male ; Medicine ; Medicine &amp; Public Health ; Methamphetamine ; Methamphetamine - adverse effects ; Original Paper ; Radiology ; Three dimensional flow ; Tracking ; Velocity ; Ventricle ; Ventricular Dysfunction, Left - chemically induced ; Ventricular Dysfunction, Left - diagnostic imaging ; Ventricular Dysfunction, Left - physiopathology ; Ventricular Function, Left - drug effects ; Ventricular Function, Left - physiology ; Young Adult</subject><ispartof>The International Journal of Cardiovascular Imaging, 2018-10, Vol.34 (10), p.1589-1593</ispartof><rights>Springer Science+Business Media B.V., part of Springer Nature 2018</rights><rights>The International Journal of Cardiovascular Imaging is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-f0f0bc1239e4307c62857f22064eb493aa1d1e09e01f994fadf8abb918afae8c3</citedby><cites>FETCH-LOGICAL-c372t-f0f0bc1239e4307c62857f22064eb493aa1d1e09e01f994fadf8abb918afae8c3</cites><orcidid>0000-0001-6038-0269</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29808387$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Li-Juan</creatorcontrib><creatorcontrib>Chen, Ke-Qi</creatorcontrib><creatorcontrib>Shi, Yun-Yan</creatorcontrib><creatorcontrib>Qiao, Xiao-Ling</creatorcontrib><creatorcontrib>Wang, Lian-You</creatorcontrib><creatorcontrib>Zheng, Xiao-Zhi</creatorcontrib><title>Findings on 3D speckle tracking echocardiography in asymptomatic methamphetamine abusers</title><title>The International Journal of Cardiovascular Imaging</title><addtitle>Int J Cardiovasc Imaging</addtitle><addtitle>Int J Cardiovasc Imaging</addtitle><description>To detect potential cardiac abnormalities in asymptomatic methamphetamine abusers using three-dimensional speckle tracking echocardiography (3D STE). Fifty-three male methamphetamine abusers, free of cardiac symptoms/signs, were enrolled in this study. A control group of 53 age-matched male normal subjects was studied for comparison. Standard 3D, flow and tissue Doppler echo with measurements of left ventricular end-diastolic volume (LVEDV), end-systolic volume (LVESV), ejection fraction (LVEF), the ratio of the early to late diastolic transmitral filling velocity (E/A), the ratio of the early diastolic transmitral filling velocity to the early diastolic septal tissue velocity (E/E′) and 3D STE with measurements of global area strain (GAS), global longitudinal strain (GLS), global circumferential strain (GCS) and global radial strain (GRS) were performed, respectively. These echocardiographic parameters were compared between methamphetamine abusers and normal subjects, and receiver operating characteristic curve (ROC) analysis was done to differentiating methamphetamine abusers from normal subjects. LVESV, LVEDV, LVEF, E/A, E/E′ ratios and GRS were not significantly different between methamphetamine abusers and normal subjects ( p  &gt; 0.05). However, GAS, GLS and GCS were significantly less in methamphetamine abusers than in normal subjects ( p  &lt; 0.05). The areas under ROC (AUC) for GAS were greatest among all the 3D STE derived LV global strains (GAS vs. GLS, GCS and GRS, 0.95 vs. 0.76, 0.69 and 0.61, respectively). The cutoff value with − 30.3% of GAS had sensitivity of 91.8%, specificity of 91.6% and accuracy of 91.3% for differentiating methamphetamine abusers from normal subjects. The potential myocardial function abnormalities can be detected by 3D STE in asymptomatic methamphetamine abusers, and GAS is a good indicator for indentifying methamphetamine abusers from normal population, which can be used to screening and monitor methamphetamine abuse, detect subclinical LV dysfunction, predict potential methamphetamine-related cardiotoxicity, and to initiate early cardioprotective therapy before the onset of overt heart failure in time.</description><subject>Abnormalities</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Amphetamine-Related Disorders - complications</subject><subject>Cardiac Imaging</subject><subject>Cardiology</subject><subject>Cardiotoxicity</subject><subject>Central Nervous System Stimulants - adverse effects</subject><subject>Drug abuse</subject><subject>Echocardiography</subject><subject>Echocardiography, Three-Dimensional</subject><subject>Heart</subject><subject>Heart diseases</subject><subject>Humans</subject><subject>Imaging</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Methamphetamine</subject><subject>Methamphetamine - adverse effects</subject><subject>Original Paper</subject><subject>Radiology</subject><subject>Three dimensional flow</subject><subject>Tracking</subject><subject>Velocity</subject><subject>Ventricle</subject><subject>Ventricular Dysfunction, Left - chemically induced</subject><subject>Ventricular Dysfunction, Left - diagnostic imaging</subject><subject>Ventricular Dysfunction, Left - physiopathology</subject><subject>Ventricular Function, Left - drug effects</subject><subject>Ventricular Function, Left - physiology</subject><subject>Young Adult</subject><issn>1569-5794</issn><issn>1573-0743</issn><issn>1875-8312</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kD1PwzAQhi0EoqXwA1iQJebA2U5ie0SFAlIlFpDYLMc5t2mbD-x06L8nVQtMTHe6ez-kh5BrBncMQN5HBlmWJsBUwoRiSX5CxiyTIgGZitP9nuskkzodkYsYVwDAgYtzMuJagRJKjsnnrGrKqllE2jZUPNLYoVtvkPbBuvVwp-iWrbOhrNpFsN1yR6uG2riru76tbV85WmO_tHW3xN7WVYPUFtuIIV6SM283Ea-Oc0I-Zk_v05dk_vb8On2YJ05I3icePBSOcaExFSBdzlUmPeeQp1ikWljLSoagEZjXOvW29MoWhWbKeovKiQm5PeR2of3aYuzNqt2GZqg0HNJMgVZaDip2ULnQxhjQmy5UtQ07w8DsWZoDSzOwNHuWJh88N8fkbVFj-ev4gTcI-EEQh1ezwPBX_X_qN8XygCU</recordid><startdate>20181001</startdate><enddate>20181001</enddate><creator>Zhang, Li-Juan</creator><creator>Chen, Ke-Qi</creator><creator>Shi, Yun-Yan</creator><creator>Qiao, Xiao-Ling</creator><creator>Wang, Lian-You</creator><creator>Zheng, Xiao-Zhi</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><orcidid>https://orcid.org/0000-0001-6038-0269</orcidid></search><sort><creationdate>20181001</creationdate><title>Findings on 3D speckle tracking echocardiography in asymptomatic methamphetamine abusers</title><author>Zhang, Li-Juan ; Chen, Ke-Qi ; Shi, Yun-Yan ; Qiao, Xiao-Ling ; Wang, Lian-You ; Zheng, Xiao-Zhi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-f0f0bc1239e4307c62857f22064eb493aa1d1e09e01f994fadf8abb918afae8c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abnormalities</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Amphetamine-Related Disorders - complications</topic><topic>Cardiac Imaging</topic><topic>Cardiology</topic><topic>Cardiotoxicity</topic><topic>Central Nervous System Stimulants - adverse effects</topic><topic>Drug abuse</topic><topic>Echocardiography</topic><topic>Echocardiography, Three-Dimensional</topic><topic>Heart</topic><topic>Heart diseases</topic><topic>Humans</topic><topic>Imaging</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Methamphetamine</topic><topic>Methamphetamine - adverse effects</topic><topic>Original Paper</topic><topic>Radiology</topic><topic>Three dimensional flow</topic><topic>Tracking</topic><topic>Velocity</topic><topic>Ventricle</topic><topic>Ventricular Dysfunction, Left - chemically induced</topic><topic>Ventricular Dysfunction, Left - diagnostic imaging</topic><topic>Ventricular Dysfunction, Left - physiopathology</topic><topic>Ventricular Function, Left - drug effects</topic><topic>Ventricular Function, Left - physiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Li-Juan</creatorcontrib><creatorcontrib>Chen, Ke-Qi</creatorcontrib><creatorcontrib>Shi, Yun-Yan</creatorcontrib><creatorcontrib>Qiao, Xiao-Ling</creatorcontrib><creatorcontrib>Wang, Lian-You</creatorcontrib><creatorcontrib>Zheng, Xiao-Zhi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (ProQuest Medical &amp; Health Databases)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>The International Journal of Cardiovascular Imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Li-Juan</au><au>Chen, Ke-Qi</au><au>Shi, Yun-Yan</au><au>Qiao, Xiao-Ling</au><au>Wang, Lian-You</au><au>Zheng, Xiao-Zhi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Findings on 3D speckle tracking echocardiography in asymptomatic methamphetamine abusers</atitle><jtitle>The International Journal of Cardiovascular Imaging</jtitle><stitle>Int J Cardiovasc Imaging</stitle><addtitle>Int J Cardiovasc Imaging</addtitle><date>2018-10-01</date><risdate>2018</risdate><volume>34</volume><issue>10</issue><spage>1589</spage><epage>1593</epage><pages>1589-1593</pages><issn>1569-5794</issn><eissn>1573-0743</eissn><eissn>1875-8312</eissn><abstract>To detect potential cardiac abnormalities in asymptomatic methamphetamine abusers using three-dimensional speckle tracking echocardiography (3D STE). Fifty-three male methamphetamine abusers, free of cardiac symptoms/signs, were enrolled in this study. A control group of 53 age-matched male normal subjects was studied for comparison. Standard 3D, flow and tissue Doppler echo with measurements of left ventricular end-diastolic volume (LVEDV), end-systolic volume (LVESV), ejection fraction (LVEF), the ratio of the early to late diastolic transmitral filling velocity (E/A), the ratio of the early diastolic transmitral filling velocity to the early diastolic septal tissue velocity (E/E′) and 3D STE with measurements of global area strain (GAS), global longitudinal strain (GLS), global circumferential strain (GCS) and global radial strain (GRS) were performed, respectively. These echocardiographic parameters were compared between methamphetamine abusers and normal subjects, and receiver operating characteristic curve (ROC) analysis was done to differentiating methamphetamine abusers from normal subjects. LVESV, LVEDV, LVEF, E/A, E/E′ ratios and GRS were not significantly different between methamphetamine abusers and normal subjects ( p  &gt; 0.05). However, GAS, GLS and GCS were significantly less in methamphetamine abusers than in normal subjects ( p  &lt; 0.05). The areas under ROC (AUC) for GAS were greatest among all the 3D STE derived LV global strains (GAS vs. GLS, GCS and GRS, 0.95 vs. 0.76, 0.69 and 0.61, respectively). The cutoff value with − 30.3% of GAS had sensitivity of 91.8%, specificity of 91.6% and accuracy of 91.3% for differentiating methamphetamine abusers from normal subjects. The potential myocardial function abnormalities can be detected by 3D STE in asymptomatic methamphetamine abusers, and GAS is a good indicator for indentifying methamphetamine abusers from normal population, which can be used to screening and monitor methamphetamine abuse, detect subclinical LV dysfunction, predict potential methamphetamine-related cardiotoxicity, and to initiate early cardioprotective therapy before the onset of overt heart failure in time.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>29808387</pmid><doi>10.1007/s10554-018-1381-6</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0001-6038-0269</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1569-5794
ispartof The International Journal of Cardiovascular Imaging, 2018-10, Vol.34 (10), p.1589-1593
issn 1569-5794
1573-0743
1875-8312
language eng
recordid cdi_proquest_journals_2045809897
source Springer Nature
subjects Abnormalities
Adolescent
Adult
Amphetamine-Related Disorders - complications
Cardiac Imaging
Cardiology
Cardiotoxicity
Central Nervous System Stimulants - adverse effects
Drug abuse
Echocardiography
Echocardiography, Three-Dimensional
Heart
Heart diseases
Humans
Imaging
Male
Medicine
Medicine & Public Health
Methamphetamine
Methamphetamine - adverse effects
Original Paper
Radiology
Three dimensional flow
Tracking
Velocity
Ventricle
Ventricular Dysfunction, Left - chemically induced
Ventricular Dysfunction, Left - diagnostic imaging
Ventricular Dysfunction, Left - physiopathology
Ventricular Function, Left - drug effects
Ventricular Function, Left - physiology
Young Adult
title Findings on 3D speckle tracking echocardiography in asymptomatic methamphetamine abusers
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T10%3A10%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Findings%20on%203D%20speckle%20tracking%20echocardiography%20in%20asymptomatic%20methamphetamine%20abusers&rft.jtitle=The%20International%20Journal%20of%20Cardiovascular%20Imaging&rft.au=Zhang,%20Li-Juan&rft.date=2018-10-01&rft.volume=34&rft.issue=10&rft.spage=1589&rft.epage=1593&rft.pages=1589-1593&rft.issn=1569-5794&rft.eissn=1573-0743&rft_id=info:doi/10.1007/s10554-018-1381-6&rft_dat=%3Cproquest_cross%3E2045809897%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-f0f0bc1239e4307c62857f22064eb493aa1d1e09e01f994fadf8abb918afae8c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2045809897&rft_id=info:pmid/29808387&rfr_iscdi=true